NSE: DRREDDY · Pharmaceuticals

Dr Reddy's Laboratories

₹1,342.00−0.74% on the day

Closing price, 2 November 2026. Delayed data.

Daily candles

Chart by TradingView: one candle per trading day, updated after each close. Live intraday prices for Indian shares and indices need an exchange licence, so free charts do not carry them.

Performance

Today's lowToday's high

₹1,336.70₹1,364.90

52-week low52-week high

₹1,101.00₹1,414.90

Open₹1,352.00

Previous close₹1,352.00

Fundamentals

Market cap₹1.12 lakh cr

P/E ratio40.00

P/B ratio2.89

ROE11.20%

EPS (TTM)₹33.55

Dividend yield0.59%

Book value₹465.00

Debt to equity—

P/E: price divided by a year's earnings per share. ROE: profit as a share of shareholders' money.

Who owns the shares

Promoters26.63%

Foreign institutions (FII)20.30%

Indian institutions (DII)31.87%

Public20.99%

Latest

Slipped 0.7% to ₹1,342 on 2 November, among the Nifty losers, as pharma shares lagged a broad rally. On 2 November it was reported to have received tentative US FDA approval, under the PEPFAR programme, for a twice-yearly injectable version of the HIV prevention drug lenacapavir.

More in Pharma & Healthcare

Cipla

₹1,387.00

+0.59%

Sun Pharmaceutical

₹1,753.10

−1.38%

Apollo Hospitals

₹8,459.00

+0.13%

Compare all Pharma & Healthcare companies

News and education only. LLUMINE Business Market News explains events and companies; it is not investment advice and does not recommend buying or selling any security. LLUMINE is not registered with SEBI as an investment adviser or research analyst. Prices are delayed and may differ from live exchange data. Markets carry risk; please do your own research or consult a SEBI-registered adviser.